NEONC TECHNOLOGIES HOLDINGS (NTHI) Fundamental Analysis & Valuation

NASDAQ:NTHI • US64051A1016

Current stock price

5.18 USD
+0.02 (+0.39%)
Last:

This NTHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NTHI Profitability Analysis

1.1 Basic Checks

  • In the past year NTHI has reported negative net income.
  • In the past year NTHI has reported a negative cash flow from operations.
NTHI Yearly Net Income VS EBIT VS OCF VS FCFNTHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1197.07%, NTHI is doing worse than 97.38% of the companies in the same industry.
Industry RankSector Rank
ROA -1197.07%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTHI Yearly ROA, ROE, ROICNTHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • NTHI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTHI Yearly Profit, Operating, Gross MarginsNTHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NTHI Health Analysis

2.1 Basic Checks

  • NTHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NTHI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NTHI Yearly Shares OutstandingNTHI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
NTHI Yearly Total Debt VS Total AssetsNTHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • NTHI has an Altman-Z score of -69.88. This is a bad value and indicates that NTHI is not financially healthy and even has some risk of bankruptcy.
  • NTHI has a worse Altman-Z score (-69.88) than 95.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -69.88
ROIC/WACCN/A
WACC9.43%
NTHI Yearly LT Debt VS Equity VS FCFNTHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 -5M -10M -15M -20M

2.3 Liquidity

  • A Current Ratio of 0.19 indicates that NTHI may have some problems paying its short term obligations.
  • NTHI has a Current ratio of 0.19. This is amonst the worse of the industry: NTHI underperforms 95.29% of its industry peers.
  • A Quick Ratio of 0.19 indicates that NTHI may have some problems paying its short term obligations.
  • NTHI's Quick ratio of 0.19 is on the low side compared to the rest of the industry. NTHI is outperformed by 94.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
NTHI Yearly Current Assets VS Current LiabilitesNTHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NTHI Growth Analysis

3.1 Past

  • NTHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -404.74%.
  • Looking at the last year, NTHI shows a very negative growth in Revenue. The Revenue has decreased by -51.81% in the last year.
  • Measured over the past years, NTHI shows a very strong growth in Revenue. The Revenue has been growing by 25.99% on average per year.
EPS 1Y (TTM)-404.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-508.32%
Revenue 1Y (TTM)-51.81%
Revenue growth 3Y25.99%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y61.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NTHI Yearly Revenue VS EstimatesNTHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 20K 40K 60K 80K
NTHI Yearly EPS VS EstimatesNTHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. NTHI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NTHI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NTHI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTHI Price Earnings VS Forward Price EarningsNTHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTHI Per share dataNTHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NTHI Dividend Analysis

5.1 Amount

  • NTHI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NTHI Fundamentals: All Metrics, Ratios and Statistics

NEONC TECHNOLOGIES HOLDINGS

NASDAQ:NTHI (4/21/2026, 2:52:59 PM)

5.18

+0.02 (+0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-31
Earnings (Next)05-07
Inst Owners8.95%
Inst Owner Change-0.04%
Ins Owners41.04%
Ins Owner Change15.92%
Market Cap129.03M
Revenue(TTM)40.00K
Net Income(TTM)-48.88M
AnalystsN/A
Price TargetN/A
Short Float %3.12%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)18.92%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2150.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.2
EYN/A
EPS(NY)-1.22
Fwd EYN/A
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0
BVpS-0.47
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1197.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -69.88
F-Score2
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-404.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-508.32%
EPS Next Y61.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-51.81%
Revenue growth 3Y25.99%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-720.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-383.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-383.26%
OCF growth 3YN/A
OCF growth 5YN/A

NEONC TECHNOLOGIES HOLDINGS / NTHI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEONC TECHNOLOGIES HOLDINGS?

ChartMill assigns a fundamental rating of 0 / 10 to NTHI.


What is the valuation status for NTHI stock?

ChartMill assigns a valuation rating of 0 / 10 to NEONC TECHNOLOGIES HOLDINGS (NTHI). This can be considered as Overvalued.


What is the profitability of NTHI stock?

NEONC TECHNOLOGIES HOLDINGS (NTHI) has a profitability rating of 0 / 10.


What is the earnings growth outlook for NEONC TECHNOLOGIES HOLDINGS?

The Earnings per Share (EPS) of NEONC TECHNOLOGIES HOLDINGS (NTHI) is expected to grow by 61.78% in the next year.